Detalhe da pesquisa
1.
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation.
Mol Cell
; 81(16): 3323-3338.e14, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34352207
2.
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.
Nature
; 593(7860): 597-601, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902106
3.
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.
Nature
; 552(7683): 126-131, 2017 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29186125
4.
The N6-methyladenosine RNA modification in acute myeloid leukemia.
Curr Opin Hematol
; 28(2): 80-85, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33337619
5.
KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements.
Leukemia
; 35(4): 1012-1022, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32764680
6.
meCLICK-Seq, a Substrate-Hijacking and RNA Degradation Strategy for the Study of RNA Methylation.
ACS Cent Sci
; 6(12): 2196-2208, 2020 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33376781
7.
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4.
Nat Commun
; 9(1): 5378, 2018 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568163